Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Journal of Cardiovascular Pharmacology and Therapeutics|June 23, 2018
Testosterone Replacement Therapy in Deficient Patients With Chronic Heart Failure: A Randomized Double-Blind Controlled Pilot StudyMarina Navarro-Peñalver, M Teresa Perez-Martinez, Manuel Gómez-Bueno, et al.
Open Heart|April 17, 2026
Epidemiology, economic burden and mortality of atrial fibrillation in a region with very high life expectancy: a contemporary, population-based analysis in CataloniaBenjamin Casteigt, Emili Vela, Ermengol Valles, et al.
European Journal of Preventive Cardiology|May 10, 2021
Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121 000 first-generation Asian immigrantsPriyanka Satish, Emili Vela, Usama Bilal, et al.
European Journal of Heart Failure|June 22, 2013
Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trialGerasimos Filippatos, Dimitrios Farmakis, Josep Comin Colet, et al.
European Journal of Heart Failure|October 13, 2018
Screening, diagnosis and treatment of iron deficiency in chronic heart failure: putting the 2016 European Society of Cardiology heart failure guidelines into clinical practiceTheresa McDonagh, Thibaud Damy, Wolfram Doehner, et al.
Journal of Personalized Medicine|March 29, 2023
Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection FractionHelena Cristóbal, Cristina Enjuanes, Montserrat Batlle, et al.
European Journal of Internal Medicine|May 23, 2020
Use of intravenous iron in patients with iron deficiency and chronic heart failure: Real-world evidenceJosé Gonzalez-Costello, Miguel Cainzos-Achirica, Josep Lupón, et al.
European Heart Journal|September 2, 2014
Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†Piotr Ponikowski, Dirk J van Veldhuisen, Josep Comin-Colet, et al.
Frontiers in Cardiovascular Medicine|December 9, 2022
Antiplatelet efficacy of ticagrelor versus clopidogrel in Mediterranean patients with diabetes mellitus and chronic coronary syndromes: A crossover pharmacodynamic investigationAna Lucrecia Marcano, Montserrat Gracida, Gerard Roura, et al.
European Journal of Heart Failure|April 25, 2017
Effects of ferric carboxymaltose on hospitalisations and mortality rates in iron-deficient heart failure patients: an individual patient data meta-analysisStefan D Anker, Bridget-Anne Kirwan, Dirk J van Veldhuisen, et al.
Pageof 15